Evidence map›Paper›PMID 34267338›Full record

SynthesisEuropean journal of human genetics : EJHG2021

A systematic review assessing the existence of pneumothorax-only variants of FLCN. Implications for lifelong surveillance of renal tumours.

Kenki Matsumoto, Derek Lim, Paul D Pharoah, Eamonn R Maher, Stefan J Marciniak

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in European journal of human genetics : EJHG, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Case Report: AFrontiers in oncology · 2022
    Article
  14. Article
  15. Genotyping arrays, population genetic studies and clinical implications.European journal of human genetics : EJHG · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kenki MatsumotoDepartment of Respiratory Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Derek LimClinical Genetics Department, Birmingham Women's and Children's NHS Foundation Trust, Edgbaston, Birmingham, UK.
Paul D PharoahCRUK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.ORCID 0000-0001-8494-732X
Eamonn R MaherDepartment of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Centre, Cambridge Biomedical Campus, Cambridge, UK.
Stefan J MarciniakDepartment of Respiratory Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. sjm20@cam.ac.uk.ORCID 0000-0001-8472-7183
University of Cambridge · GBBirmingham Women’s and Children’s NHS Foundation Trust · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Medical Research Council G1002610Medical Research Council MR/V028669/1
6 · The paper itself

Abstract

Individuals with Birt-Hogg-Dubé syndrome (BHDS) may develop fibrofolliculomas, pneumothorax and/or renal cell carcinoma (RCC). Currently, all patients with pathogenic FLCN variants are recommended to have renal surveillance. It has however been suggested that some FLCN variants only cause pneumothorax, which would make surveillance unnecessary in certain cases. This review assesses this possibility. We provide an up-to-date analysis of clinical and genetic features of BHDS. The PUBMED database was systematically searched to find all articles describing patients with pathogenic FLCN variants. The relevant clinical and genetic features of these patients were recorded and analysed. The prevalence of pneumothorax, pulmonary cysts, RCC and characteristic skin lesions in BHDS were 50.9% (n = 1038), 91.9% (n = 720), 22.5% (n = 929) and 47.9% (n = 989), respectively. There was a higher prevalence of pneumothoraces (p < 0.0001) but lower prevalence of dermatological findings (p < 0.0001) in patients from East Asia compared to North America or Europe. Of the 194 pathogenic FLCN variants, 76 could be defined as 'pneumothorax-only'. Pneumothorax only pathogenic variants (POPVs) were distributed throughout the gene, and there were no statistical differences in variant type. The majority of POPVs (65/76) affected no more than three individuals. Individuals with 'POPVs' also tended to be younger (45 vs. 47 years, p < 0.05). Many apparent POPVs in the literature could result from variable expressivity, age-related penetrance and other confounding factors. We therefore recommend that all individuals found to carry a pathogenic FLCN variant be enroled in lifelong surveillance for RCC.

Indexed as

PhenotypeBirt-Hogg-Dube SyndromeHumansKidney NeoplasmsMutationPneumothoraxProto-Oncogene ProteinsTumor Suppressor ProteinsFLCN protein, humanProto-Oncogene ProteinsTumor Suppressor Proteins

Identifiers

PMID34267338
PMCPMC8560836
OpenAlexW3181597566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.